NCT04832945View on ClinicalTrials.gov

SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin Retrospective Cohort Study

CompletedOBSERVATIONAL
Enrollment

713

Participants

Timeline

Start Date

June 29, 2020

Primary Completion Date

September 20, 2020

Study Completion Date

April 10, 2021

Conditions
Covid19
Interventions
DRUG

Ivermectin 6 Mg Oral Tablet

Ivermectin weekly oral dose 0.2 mg/kg equivalent for 4 weeks

Trial Locations (2)

23000

Centro Médico Punta Cana, Punta Cana

57000

Centro Medico Bournigal, Puerto Plata

All Listed Sponsors
lead

Grupo Rescue S.A.S República Dominicana

NETWORK

NCT04832945 - SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin Retrospective Cohort Study | Biotech Hunter | Biotech Hunter